CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
Contact force assisted irrigated RF ablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01223469
NCT01223469N/ACompleted

A Prospective Safety, Performance and Preliminary Effectiveness, Multi-centre, Clinical Investigation Using the Irrigated TactiCath™ Percutaneous Ablation Catheter for the Treatment of Supra-Ventricular Tachyarrhythmia Using RF Ablation

Abbott Medical Devices·interventional·Posted Oct 19, 2010·Updated Jan 30, 2019

In Brief

A clinical study evaluating Contact force assisted irrigated RF ablation for Atrial Fibrillation and Tachycardia, Supraventricular. Completed, enrolled 77 participants.

Detailed Summary

The main objective of this study is to demonstrate the clinical safety of a contact force sensing RF ablation catheter when used for the treatment of supraventricular tachycardia and atrial fibrillation. In addition, the study will characterize the use and value of contact force measurement during ablation, and the long term success (12 months) of the ablation procedure using this technology.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
CollaboratorsEndosense

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 19, 2010
Enrollment StartSep 1, 2008
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 15.7 years ago

Interventions

Contact force assisted irrigated RF ablationdevice

radiofrequency ablation of atrial fibrillation or SVT